DeCode s Shares Rebound After Mid-day Dip Following Positive Drug Data

genomeweb
360dx

DeCode s Shares Rebound After Mid-day Dip Following Positive Drug Data

Oct 20, 2004

This article has been updated from a previous version. Share prices have been updated.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Human Sex Reversal Tied to Enhancer Mutations Near SOX9 Gene
People in the News: Catherine Friedman, Daniel O'Day, Prahlad Singh, More
In Brief This Week: Cancer Research UK, NeoGenomics, Luminex, and More
Metastatic Colorectal Cancer Linked to Transcription Factors, Gene Networks
Genome Editing Patterns Could Help Predict CRISPR Outcomes
New Products Posted to GenomeWeb: Cellecta, Indigo, Expedeon, More

The Scan

Faster Profiles

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

Standards Needed

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

Conflict Search

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

This Week in Science

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Main menu